SELLAS Life Sciences Group Inc (SLS)
1.155
-0.08
(-6.85%)
USD |
NASDAQ |
May 01, 12:27
SELLAS Life Sciences Group Total Assets (Quarterly): 6.219M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.219M |
| September 30, 2023 | 8.086M |
| June 30, 2023 | 18.57M |
| March 31, 2023 | 29.10M |
| December 31, 2022 | 20.94M |
| September 30, 2022 | 26.00M |
| June 30, 2022 | 32.21M |
| March 31, 2022 | 21.43M |
| December 31, 2021 | 26.28M |
| September 30, 2021 | 37.95M |
| June 30, 2021 | 43.62M |
| March 31, 2021 | 40.58M |
| December 31, 2020 | 46.05M |
| September 30, 2020 | 18.51M |
| June 30, 2020 | 14.51M |
| March 31, 2020 | 17.03M |
| December 31, 2019 | 16.61M |
| September 30, 2019 | 21.48M |
| June 30, 2019 | 25.03M |
| March 31, 2019 | 14.93M |
| December 31, 2018 | 16.92M |
| September 30, 2018 | 38.47M |
| June 30, 2018 | 31.97M |
| March 31, 2018 | 33.48M |
| December 31, 2017 | 33.53M |
| Date | Value |
|---|---|
| September 30, 2017 | 49.60M |
| June 30, 2017 | 60.55M |
| March 31, 2017 | 70.33M |
| December 31, 2016 | 6.42M |
| September 30, 2016 | 72.85M |
| June 30, 2016 | 73.78M |
| March 31, 2016 | 66.36M |
| December 31, 2015 | 82.14M |
| September 30, 2015 | 82.67M |
| June 30, 2015 | 101.97M |
| March 31, 2015 | 108.61M |
| December 31, 2014 | 80.49M |
| September 30, 2014 | 79.49M |
| June 30, 2014 | 80.28M |
| March 31, 2014 | 92.29M |
| December 31, 2013 | 87.98M |
| September 30, 2013 | 91.25M |
| June 30, 2013 | 62.00M |
| March 31, 2013 | 61.45M |
| December 31, 2012 | 54.99M |
| September 30, 2012 | 35.19M |
| June 30, 2012 | 38.96M |
| March 31, 2012 | 28.21M |
| December 31, 2011 | 30.97M |
| September 30, 2011 | 30.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
6.219M
Minimum
Dec 2023
46.05M
Maximum
Dec 2020
24.75M
Average
21.48M
Median
Sep 2019
Total Assets (Quarterly) Benchmarks
| Geron Corp | 394.08M |
| Immuneering Corp | 102.58M |
| Protagonist Therapeutics Inc | 357.95M |
| Akebia Therapeutics Inc | 241.70M |
| Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.20M |
| Shareholders Equity (Quarterly) | -7.976M |